Mark Stenhouse

Insider Reports History

Location
Madison, WI
Signature
/s/ Steven Basta, Attorney-in-Fact for Mark Stenhouse
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Stenhouse:

Company Role Class Num Shares Value Price $ Report Date Ownership
Phathom Pharmaceuticals, Inc. Director Common Stock 30,000 $99,300 $3.31 03 Jun 2025 Direct
Phathom Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 17,500 03 Jun 2025 Direct
Prometheus Biosciences, Inc. Chief Operating Officer Common Stock 0 $108.42 16 Jun 2023 By Stenhouse Family Fund
Prometheus Biosciences, Inc. Chief Operating Officer Common Stock 0 $108.42 16 Jun 2023 Direct
Prometheus Biosciences, Inc. Chief Operating Officer Stock Option (right to buy) 0 16 Jun 2023 Direct

Insider Reports Filed by Mark Stenhouse

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PHAT Phathom Pharmaceuticals, Inc. 03 Jun 2025 2 $0 4 Director 05 Jun 2025, 16:55
PHAT Phathom Pharmaceuticals, Inc. 23 May 2024 2 $0 4 Director 24 May 2024, 19:18
RXDX Prometheus Biosciences, Inc. 16 Jun 2023 7 $0 4 Chief Operating Officer 16 Jun 2023, 16:00
RXDX Prometheus Biosciences, Inc. 01 Jun 2023 2 $0 4 Chief Operating Officer 02 Jun 2023, 18:57
PHAT Phathom Pharmaceuticals, Inc. 25 May 2023 2 $0 4 Director 30 May 2023, 19:01
RXDX Prometheus Biosciences, Inc. 09 Dec 2022 2 $0 4 Chief Operating Officer 13 Dec 2022, 19:38
PHAT Phathom Pharmaceuticals, Inc. 25 May 2022 1 $0 4 Director 27 May 2022, 16:50
RXDX Prometheus Biosciences, Inc. 20 May 2022 1 $0 4 Chief Operating Officer 20 May 2022, 19:15
RXDX Prometheus Biosciences, Inc. 14 Nov 2021 1 $0 4 Chief Operating Officer 16 Nov 2021, 20:10
PHAT Phathom Pharmaceuticals, Inc. 21 May 2021 1 $0 4 Director 24 May 2021, 17:44